AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost?

LETTER TO THE EDITOR

James A. Charles MD,

Corresponding Author

Holy Name Medical Center, Teaneck, New Jersey, USA

Correspondence

James A. Charles, Neurosciences, New Jersey Medical School, 956 Kennedy Boulevard, Bayonne, NJ 07002, USA.

Email: Jacharlesmd@gmail.com

Search for more papers by this authorIra M. Turner MD,

PC – Headache, Island Neurological Associates, Plainview, New York, USA

Search for more papers by this author PDFPDF Please review our Terms and Conditions of Use and check box below to share full-text version of article.

I have read and accept the Wiley Online Library Terms and Conditions of Use

Shareable Link

Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.

Share a link

Share on

No abstract is available for this article.

留言 (0)

沒有登入
gif